期刊文献+

间充质干细胞在重症哮喘治疗中的机制和前景 被引量:3

Mechanism and prospect of mesenchymal stem cells in the treatment of severe asthma
原文传递
导出
摘要 重症哮喘是哮喘防治的难点和重点。全球范围内,重症哮喘给社会和家庭带来的负担愈发沉重。目前糖皮质激素仍然是治疗重症哮喘的主要手段,但长期口服或全身糖皮质激素维持治疗可引发各种严重的不良事件。因此寻找新的治疗措施,对于重症哮喘治疗而言具有重要意义。近几年间充质干细胞因其免疫调节能力而成为治疗各种疾病的一种新方式。研究发现间充质干细在治疗呼吸道疾病中也具有很好的应用前景。本文就间充质干细胞治疗的机制以及其在重症哮喘的应用前景展开重点讨论,为间充质干细胞下一步在重症哮喘中的临床应用提供理论依据。
作者 李春晓 林江涛 Li Chunxiao;Lin Jiangtao
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2021年第6期591-596,共6页 Chinese Journal of Tuberculosis and Respiratory Diseases
  • 相关文献

参考文献4

二级参考文献36

  • 1[1]Ganji A,Safavi M,Nouraie SM,Nasseri-Moghadam S,Merat Sh,Vahedi H,Malekzadeh R.Digestive and liver diseases statistics in several referral centers in Tehran,2000-2004.Govaresh 2006; 11:33-38
  • 2[2]Malek-Hosseini SA,Mehdizadeh AR,Salahi H,Saberi-Firouzi M,Bagheri-Lankarani K,Bahador A,Imanieh MH,Nik-Eghbalian S,Lahsaee M,Khosravi MB,Arasteh MM,Bagheri MH,Geramizadeh B,Razmkon A,Tabei SZ.Results of liver transplantation:analysis of 140 cases at a single center.Transplant Proc 2005; 37:3157-3158
  • 3[3]Sakaida I,Terai S,Nishina H,Okita K.Development of cell therapy using autologous bone marrow cells for liver cirrhosis.Med Mol Morphol 2005; 38:197-202
  • 4[4]Schachinger V,Erbs S,Elsasser A,Haberbosch W,Hambrecht R,Holschermann H,Yu J,Corti R,Mathey DG,Hamm CW,Suselbeck T,Assmus B,Tonn T,Dimmeler S,Zeiher AM.Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.N Engl J Med 2006; 355:1210-1221
  • 5[5]Almeida-Porada G,Porada CD,Chamberlain J,Torabi A,Zanjani ED.Formation of human hepatocytes by human hematopoietic stem cells in sheep.Blood 2004; 104:2582-2590
  • 6[6]Sakaida I,Terai S,Yamamoto N,Aoyama K,Ishikawa T,Nishina H,Okita K.Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.Hepatology 2004;40:1304-1311
  • 7[7]am Esch JS 2nd,Knoefel WT,Klein M,Ghodsizad A,Fuerst G,Poll LW,Piechaczek C,Burchardt ER,Feifel N,Stoldt V,Stockschlader M,Stoecklein N,Tustas RY,Eisenberger CF,Peiper M,Haussinger D,Hosch SB.Portal application of autologous CD133+ bone marrow cells to the liver:a novel concept to support hepatic regeneration.Stem Cells 2005; 23:463-470
  • 8[8]Montazeri A,Goshtasebi A,Vahdaninia M,Gandek B.The Short Form Health Survey (SF-36):translation and validation study of the Iranian version.Qual Life Res 2005; 14:875-882
  • 9[9]Mohyeddin Bonab M,Yazdanbakhsh S,Alimoghaddam K,Talebian F,Hooshmand F,Lotfi J,Ghavamzadeh A.Mesenchymal stem cell therapy for multiple sclerosis.Int J Hematol Oncol BMT 2005; 2:10-16
  • 10[10]Snyder EY,Daley GQ,Goodell M.Taking stock and planning for the next decade:realistic prospects for stem cell therapies for the nervous system.J Neurosci Res 2004; 76:157-168

共引文献107

同被引文献16

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部